anmelden
OMX Stockholm PI
1.062,47
PKT
-15,23
PKT
-1,41
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.06.18 | Hennes Mauritz (H M, H&M) Verkaufen | DZ BANK | |
| 28.06.18 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 28.06.18 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 27.06.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.06.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 26.06.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 25.06.18 | AstraZeneca Neutral | UBS AG | |
| 25.06.18 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Kepler Cheuvreux | |
| 25.06.18 | Nokia Neutral | Credit Suisse Group | |
| 22.06.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.06.18 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Société Générale Group S.A. (SG) | |
| 19.06.18 | Nokia Neutral | BNP PARIBAS | |
| 18.06.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.06.18 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Credit Suisse Group | |
| 15.06.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 13.06.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 12.06.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 11.06.18 | Volvo (B) buy | Citigroup Corp. | |
| 11.06.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 07.06.18 | Volvo (B) Sell | UBS AG | |
| 06.06.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.06.18 | AstraZeneca buy | Deutsche Bank AG | |
| 30.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.05.18 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.05.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 24.05.18 | AstraZeneca Hold | S&P Capital IQ | |
| 22.05.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 22.05.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 22.05.18 | AstraZeneca overweight | Barclays Capital | |
| 22.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 22.05.18 | AstraZeneca buy | Deutsche Bank AG | |
| 18.05.18 | AstraZeneca Neutral | UBS AG | |
| 18.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 15.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.05.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.05.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 11.05.18 | AstraZeneca overweight | Barclays Capital | |
| 08.05.18 | Nokia overweight | JP Morgan Chase & Co. |